Amryt Pharma's LON:AMYT) Rory Nealon presents at the Proactive One2One virtual conference.
Amryt Pharma is a commercial stage pharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of people with rare and orphan diseases.
The company recently outligned plans to share additional encouraging data on its recent successful phase III study of FILSUVEZ to the medical and financial communities.